Elevance Health Inc.
ELVNYSEHealthcare● Active
$418.85
+$3.32(+0.80%)
Market Cap$91.0B
P/E Ratio—
52W High$421.17
52W Low$273.71
Elevance Health Inc. (ELV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ELV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $199.13B | $176.81B | $171.34B | $156.59B | $138.64B |
| Cost of Revenue | $148.22B | $127.57B | $124.33B | $116.64B | $102.64B |
| Gross Profit | $50.90B | $49.24B | $47.01B | $39.95B | $35.99B |
| Gross Margin %(computed) | 25.56% | 27.85% | 27.44% | 25.51% | 25.96% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $42.79B | $40.35B | $38.27B | $31.50B | $27.05B |
| Operating Income | $8.11B | $8.89B | $8.74B | $8.45B | $8.95B |
| Operating Margin %(computed) | 4.07% | 5.03% | 5.10% | 5.40% | 6.45% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $1.40B | $1.19B | $1.03B | $0.85B | $0.80B |
| Income Before Tax | $6.71B | $7.90B | $7.71B | $7.60B | $7.92B |
| Income Tax Expense | $1.05B | $1.93B | $1.72B | $1.71B | $1.83B |
| Net Income | $5.66B | $5.98B | $5.99B | $5.89B | $6.10B |
| Net Margin %(computed) | 2.84% | 3.38% | 3.49% | 3.76% | 4.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $25.18 | $25.81 | $25.38 | $24.56 | $25.25 |
| Wtd Avg Shares | 0.22B | 0.23B | 0.23B | 0.24B | 0.24B |
| EBITDA | $9.66B | $10.48B | $10.49B | $10.13B | $10.03B |
| EBITDA Margin %(computed) | 4.85% | 5.93% | 6.12% | 6.47% | 7.23% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Elevance Health Inc. data
About Elevance Health Inc. (ELV) Income Statement
Elevance Health Inc. (ELV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ELV reported revenue of $199.13B, gross profit of $50.90B (gross margin 25.56%), and net income of $5.66B — a net profit margin of 2.84%.
Frequently asked questions
ELV · 4 questionsElevance Health Inc. (ELV) reported revenue of $199.13B for 2025, up 12.6% year-over-year.
ELV revenueELV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08